Sana biotechnology stock.

Get the latest stock price, quote, news and history of Sana Biotechnology, Inc. Common Stock (SANA), a biotechnology company that develops and commercializes products for the treatment of cancer and other diseases. See real-time data, market cap, key data and news of SANA on Nasdaq.General and administrative expenses for the three and six months ended June 30, 2022 include stock-based compensation of $2.5 million and $4.5 million, respectively, and $1.8 million and $3.3 million for the same periods in 2021. Net Loss: Net loss for the three and six months ended June 30, 2022 was $72.5 million, or $0.39 per share, ...The advantages of biotechnology include curing infectious diseases, creating more efficient fuels and increasing farming yields to feed more people. Disadvantages of biotechnology include antibiotic resistant bacteria, new allergic reaction...SEATTLE, May 08, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial results and business highlights for the first quarter 2023. ... Washington, and other allocated costs. Research and development expenses include …5 brokers have issued 12-month price targets for Sana Biotechnology's stock. Their SANA share price targets range from $8.00 to $13.00. On average, they anticipate the company's share price to reach $10.00 in the next year. This suggests a possible upside of 135.8% from the stock's current price.

According to the issued ratings of 5 analysts in the last year, the consensus rating for Sana Biotechnology stock is Moderate Buy based on the current 2 hold ratings and 3 buy ratings for SANA. The average twelve-month price prediction for Sana Biotechnology is $10.00 with a high price target of $13.00 and a low price target of $8.00.

Today, Sana is a public company. It did raise prodigious sums, $700 million in a Series A and another $585 million in an IPO. Yet disease — well, disease remains with us. The biotech’s hopes ...

Stock Symbol NASDAQ:SANA. Acquisitions 1. Total Funding Amount $700M. Total Funding Amount . Unlock for free . Contacts 321. Employee Profiles 22. Investors 13. ... Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or …The average price recommended by analysts for Sana Biotechnology Inc (SANA) is $9.00, which is $4.76 above the current market price. The public float for SANA is 98.43M and currently, short sellers hold a 22.73% of that float. On November 16, 2023, SANA’s average trading volume was 1.20M shares. SANA) stock’s latest price updateWhat's Happening With Sana Biotechnology Inc Stock Today? Sana Biotechnology Inc (SANA) stock is trading at $3.58 as of 11:15 AM on Monday, Dec 4, a decline of -$0.46, or -11.39% from the previous closing price of $4.04. The stock has traded between $3.51 and $4.10 so far today. Volume today is less active than usual.Dec 4, 2023 · The company, currently valued at $163.76M, closed the last trade at $1.44 per share which meant it gained $0.11 on the day or 8.27% during that session. The ESPR stock price is -515.97% off its 52-week high price of $8.87 and 51.39% above the 52-week low of $0.70. If we look at the company’s 10-day average daily trading volume, we find that ...

See the latest Sana Biotechnology Inc Ordinary Shares stock price (SANA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Cell therapy and gene repair company Sana Biotechnology Inc., which raised nearly $600 million in an IPO at the height of the biotech boom, said Tuesday it plans to cut about 15% of its workforce ...

Feb 4, 2021 · Sana arrived at $587.5 million by selling fewer shares than it had planned to at a slightly higher price—23,500,000 shares at $25 apiece rather than the planned 25,300,000 shares at $24 apiece. Sana Biotechnology, Inc. 188 East Blaine Street Suite 400 Seattle, WA 98102 United States 206 701 7914 https://www.sana.com Sector(s) : Healthcare Industry : Biotechnology Full Time Employees : 418Real time Sana Biotechnology (SANA) stock price quote, stock graph, news & analysis. Accessibility Log ... Sana Biotechnology, Inc. engages in the research and development of engineered cells as ...Sana Biotechnology, which raised a whopping $588 million in its initial public offering last year, has inked a deal for new manufacturing space.. The preclinical-stage biotech is ditching plans to ...We would like to show you a description here but the site won’t allow us.SEATTLE, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through... Green Stock News for the New Green Economy. Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune …Cabaletta Bio Inc (NASDAQ:CABA) has a beta value of 2.42 and has seen 1.25 million shares traded in the last trading session. The company, currently valued at $686.46M, closed the last trade at $16.02 per share which meant it lost -$0.03 on the day or -0.19% during that session.

According to the issued ratings of 5 analysts in the last year, the consensus rating for Sana Biotechnology stock is Moderate Buy based on the current 2 hold ratings and 3 buy ratings for SANA. The average twelve-month price prediction for Sana Biotechnology is $10.00 with a high price target of $13.00 and a low price target of $8.00.Introduction: The ability to deliver genes to specific cell types in vivo would have a profound therapeutic impact for a diverse set of diseases. For example, targeting T cells for in vivo delivery of a chimeric antigen receptor (CAR) to treat B cell malignancies would improve access to CAR T therapies by overcoming the limitations of ex vivo …Dec 4, 2023 · The GMDA stock price is -660.61% off its 52-week high price of $2.51 and 33.33% above the 52-week low of $0.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.03 million shares traded. The 3-month trading volume is 1.77 million shares. The consensus among analysts is that Gamida Cell Ltd (GMDA) is ... The Sana stock price is currently $4.76. The above agreements are part and parcel for many biotech startups, but investors need to consider what they mean as they may significantly dent their upside.Sana Biotechnology, Inc. (the "Company") intends to discuss an updated corporate presentation (the "Corporate Presentation") at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023. A copy of the Corporate Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and …We would like to show you a description here but the site won’t allow us.

Sana Biotechnology Inc (NASDAQ:SANA) has a beta value of 1.22 and has seen 1.54 million shares traded in the last trading session. The company, currently Gamida Cell Ltd (GMDA): What Is Good About Stock?

Engineered cells as medicines. Repairing and controlling genes in cells or replacing missing or damaged cells can solve the underlying cause of many diseases. These emerging capabilities will create novel medicines that meaningfully improve patient outcomes, and Sana aims to lead the way. Sana is creating engineered cells to repair and control ... [relinking] Home Product Place Promotion Price Sana Biotechnology, Inc. (SANA) reported a revenue of $12.7 million in the first quarter of 2022. The company's net loss for the same period was $37.6 million. SANA's stock price as of September 2022 was $25.08 per share. SANA's marketing mix strategy includes a focus on developing innovative products in …Sana recognized a non-cash gain of $9.9 million for the three months ended December 31, 2021 and a non-cash expense of $57.9 million for the twelve months ended December 31, 2021. The value of these potential liabilities may fluctuate significantly with changes in Sana’s market capitalization and stock price.Expects to present data at multiple scientific conferences in 20212020 year-end cash position of $412 millionFurther strengthened cash position wi...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Sana Biotechnology Stock Performance. SANA opened at $4.24 on Tuesday. The business’s 50-day simple moving average is $3.59 and its 200 day simple moving average is $5.10. Sana Biotechnology, Inc. has a 52-week low of $2.74 and a 52-week high of $8.01. The firm has a market capitalization of $835.83 million, a PE ratio of -2.94 and a beta of ...SANA: Sana Biotechnology Inc Stock Price Quote - NASDAQ GS - Bloomberg Subscribe S&P 500 4,559.34 +0.06% Nasdaq 14,250.85 –0.11% Crude Oil 75.18 –2.49% US 10 Yr …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged ...

Nov 27, 2023 · 5 brokers have issued 12-month price targets for Sana Biotechnology's stock. Their SANA share price targets range from $8.00 to $13.00. On average, they anticipate the company's share price to reach $10.00 in the next year. This suggests a possible upside of 135.8% from the stock's current price.

Mar 16, 2023 · Sana recognized a non-cash gain of $9.9 million for the three months ended December 31, 2021 and a non-cash expense of $57.9 million for the twelve months ended December 31, 2021. The value of these potential liabilities may fluctuate significantly with changes in Sana’s market capitalization and stock price. Dec 1, 2023 · Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and ... Discover historical prices for SANA stock on Yahoo Finance. View daily, weekly or monthly format back to when Sana Biotechnology, Inc. stock was issued. May 24, 2023 · In a report released today, Emily Bodnar from H.C. Wainwright reiterated a Hold rating on Sana Biotechnology ( SANA – Research Report ). The company’s shares closed yesterday at $7.09. Bodnar ... The net loss for the quarter was $82.1 million, up from $31.4 million in the same period in 2022. Per Seeking Alpha data: SANA's stock shows mixed momentum over various time frames. Over the last ...SEATTLE, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the closing of its upsized initial public offering of 27,025,000 shares of its common stock at a public offering price of $25.00 per share, which includes the full ...SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial ...View the latest Sana Biotechnology Inc. (SANA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

1.45%. $369.91M. SANA | Complete Sana Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. About Sana Biotechnology ... On October 31, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK. Since its inception, Innovent has ...The Sana Biotechnology, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at …Sana prices upsized IPO at $25, above the expected range, trades today. Get the latest news and real-time alerts from Sana Biotechnology, Inc. (SANA) stock at Seeking Alpha.Instagram:https://instagram. greek mansionstock portfolio tracker apprumble stock predictionaccuray incorporated The company, currently valued at $163.76M, closed the last trade at $1.44 per share which meant it gained $0.11 on the day or 8.27% during that session. The ESPR stock price is -515.97% off its 52-week high price of $8.87 and 51.39% above the 52-week low of $0.70. If we look at the company’s 10-day average daily trading volume, we find … expense reporting app freevaipx stock price Sana Biotechnology, Inc. (SANA) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.2400 -0.1400 (-3.20%) At close: 04:00PM EST … how to paper trade on webull mobile Learn about Sana Biotechnology, Inc. (SANA) stock's management team. Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team. ... Sana Biotechnology's CEO is Steve Harr, appointed in Sep 2018, has a tenure of 5.17 years. total yearly compensation is $3.81M, comprised of 16.9% salary and 83.1% bonuses, …Nov 17, 2023 · 8-K. Nov 08, 2023. Quarterly report which provides a continuing view of a company's financial position. 10-Q. Nov 03, 2023. Statement of changes in beneficial ownership of securities. 4. The Investor Relations website contains information about Sana Biotechnology, Inc's business for stockholders, potential investors, and financial analysts.